Targeting Microbiota 2020 will be a Virtual and in-Person Congress

We have been closely following updates and evolving guidance from local, national and global agencies for COVID-19. There is still much uncertainty around the coronavirus, and how long our communities may be impacted by the pandemic, but it seems certain that decisions about how we work, travel and gather together will continue to be influenced for weeks and months still to come. Today we have made the decision to combine in-person and Virtual conference.

 

If you cannot attend in-person or virtual due to the restriction and time zone difference, you can access on-demand videos to this entire event, including synced audio/video and slides.

All posters will be in PDF format. You can visit them, upload and interact directly with the poster presenter. You can also exchange with speakers via direct or private exchange during the conference.

We will keep you informed of any new decision.

Welcome to Targeting Microbiota 2020

President Targeting Microbiota 2020Dear colleagues,


On behalf of the International Society of Microbiota, we are pleased to inform you that the 8th World Congress on Targeting Microbiota will be organized at UNESCO World Heritage Centre - Paris, France, on
October 21-23, 2020. 

Read More...


Metabolic and Metagenomic Consequences of E. coli Infections

Matteo SERINO Targeting Microbiota 2019The Scientific Committee of Targeting Microbiota 2019 Congress invited Dr. Matteo Serino from Inserm and Digestive Health Research Institute, France.

Dr. Serino will give a presentation entitled "Metabolic and Metagenomic Consequences of E. coli Infections".

Summary of Presentation: A dietary fat enrichment is among the strongest factors impacting on gut microbiota on a both structural and functional level, as well known as inducer of metabolic diseases such as obesity, type 2 diabetes and hepatopathology. Interestingly, an alimentary switch towards the high-fat content has been also shown  capable of favouring the colonisation of the intestine by enterobacteria. Among the latters are pro-inflammatory and/or genotoxic E. coli strains. The metabolic consequences of the infections by these bacteria in mice will be discussed in relation to a lean vs. an obese/diabetic host, together with changes in the gut microbiota and microbiome.

For more information: www.microbiota-site.com

 

Microbiota World Congress 2019

bouton more pictures

Microbiota in the Press & Media

  • 1
  • 2
  • 3
Prev Next